Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Xellar Biosystems has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Xellar Biosystems's investors include Legend Capital, XtalPi, Tiantu Capital, China Life Private Equity Investment, Zhengxuan Investment.
Xellar Biosystems is headquartered in Newton, United States.
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Xellar Biosystems is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xellar Biosystems — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/xellar-biosystems. Accessed October 23, 2026.
VCBacked. (2026). Xellar Biosystems — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/xellar-biosystems
{{cite web |title=Xellar Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/xellar-biosystems |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated